Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0965-2026Class II

LifeShield Drug Library Management (DLM); LifeShield Infusion Safety Software Suite v2.2 List Number 17003-02

Abbott Medical / initiated 2025-11-24 / Open, Classified / root cause: software

ICU Medical, Inc. began a recall of LifeShield Drug Library Management (DLM); LifeShield Infusion Safety Software Suite v2.2 List Number 17003-02 on . FDA classified it as Class II and gives the reason as "For certain customers, the Change Summary review option ceases to operate as expected for any migrated library after the migration has been completed. Users must use alternate methods to review changes. Failure to do so...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-0965-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Abbott Medical
Product
LifeShield Drug Library Management (DLM); LifeShield Infusion Safety Software Suite v2.2 List Number 17003-02
Product code
PHC Infusion Safety Management Software
Reason for recall
For certain customers, the Change Summary review option ceases to operate as expected for any migrated library after the migration has been completed. Users must use alternate methods to review changes. Failure to do so may lead in over delivery, under delivery, or delay in setup on the infusion pump.
Root cause tag
software
FDA root cause
Software Design Change
Action
Firm began notifying customers on 11/24/2025 via Urgent Medical Device Correction letters. Customers were instructed to ensure all users or potential users of LifeShield ISSS DLM 2.2.1 with Plum Duo 1.1 drug libraries are made aware of the issue and the following proposed mitigations: Until a software update is released, when performing the first Plum Duo v1.1 drug library review after the migration, the pharmacist is able to review the changes using alternate review mechanisms, as noted in the LifeShield Drug Library Management User Manual: a) Accessing the version history view of the drug library b) Review drug library reports in CSV or HTML format c) Assess each change within LifeShield DLM to verify the accuracy of the changes (i.e., view impacted medication ruleset hard dose rate limit or view a CCA to verify a maximum rate setting) The firm is developing a software update to correct the issue and will notify customers of the timing of the software update.
Quantity in commerce
7 customers
Distribution
US Nationwide distribution in the states of CA, IA, LA, NY, PA, TN, VA.
Product codes and lots
version 2.2.1 UDI-DI 00887709127227 Issue affects customers who migrated from LifeShield DLM v2.1x to LifeShield DLM v2.2.1 and have any version of a Plum Duo v1.1 drug library that was approved or locked for review before the migration.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0965-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0965-2026Class IIOngoingVoluntary: Firm initiated